The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities

News

The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities

15.07.2020 News

Pfizer and BioNTech shares rose sharply on Monday by 4% and 10%, respectively. This happened after the US Food and Drug Administration (FDA) assigned an “accelerated” status to their two COVID-19 potential vaccines.

Although the companies have not yet completed the final tests and have not received approval for the production and sale of their vaccine, the status gives them a chance to accelerate the transition to these stages. It also gives a chance that their vaccine will receive a FDA “priority review” status, which means that management can decide on approval within six months.

In early July, they said that phase 2 of clinical trials of a vaccine BNT162b1 showed that all 24 volunteers who received two injections had a “strong immune response” to the virus. It was even stronger than that patients who underwent COVID-19 had.

While data on these trials is due to be released this month, today Pfizer and BioNTech intend to move on to testing the most promising of the potential vaccines with up to 30,000 participants in the United States and Europe.

“The FDA’s decision to grant these two COVID-19 vaccines an ‘accelerated status’ is an important milestone in efforts to develop a safe and effective SARS-CoV-2 vaccine,” said Peter Honig, Pfizer’s Senior Vice President of global regulation. “We look forward to continuing to work closely with the FDA throughout the clinical development of this Project Lightspeed program to evaluate the safety and efficiency of these vaccines.”

According to Pfizer, if regulators eventually approve the drug, Pfizer and BioNTech will deliver up to 100 million doses by the end of the year and at least another 1.2 billion by the end of 2021.

Moderna which is developing a potential vaccine using technology similar to Pfizer and BioNTech received the same “accelerated” status in May for its COVID-19 vaccine candidate.

Moderna shares jumped 14.65% on Monday because of the news that they will be added to the Nasdaq-100 index before the market opens on July 20.

Analysts estimate the potential annual revenue from global COVID-19 vaccine sales at $5 to $10 billion.

Other articles

  • Pfizer will deliver half of the planned number of vaccines in 2020
    News

    Pfizer will deliver half of the planned number of vaccines in 2020

    Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

  • Moderna vaccine will be tested on teenagers
    News

    Moderna vaccine will be tested on teenagers

    The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]

  • Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19
    News

    Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19

    Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]

  • The Nikkei index has become the highest since 1991
    News

    The Nikkei index has become the highest since 1991

    Trading on Asia’s largest stock exchange on Asia on Tuesday opened another rise amid the continuing strengthening of indices in New York. This is evidenced by the data of stock trading on the website of the Tokyo Stock Exchange. The Nikkei index, which reflects fluctuations in the stock prices of 225 leading companies in the […]

  • Shares of Moderna rose by almost 20% after news of the vaccine
    News

    Shares of Moderna rose by almost 20% after news of the vaccine

    The vaccine, developed by biotechnology company Moderna, is effective in 94.5% of cases. This result was shown by the intermediate results of the third phase of clinical trials, the company said. On this news, Moderna shares went up. In the pre-market, the company’s quoting rose by more than 18%, rising above $ 105 per share. […]

  • Citigroup predicted the dollar to fall by 20% next year
    News

    Citigroup predicted the dollar to fall by 20% next year

    If coronavirus vaccines become widely available and help restore international trade and economic growth, the dollar is likely to fall by 20% in 2021. Bloomberg reports that this forecast was made by Citigroup Bank. If the forecast comes true, it will be a record drop since 1985, when the DXY index fell by 18.5% over […]

  • The Moderna vaccine has been tested. It can be approved at an accelerated rate
    News

    The Moderna vaccine has been tested. It can be approved at an accelerated rate

    Reuters reported, In Switzerland, the procedure of accelerated testing of Moderna vaccine has started. This will allow to approve the drug if it passes all clinical trials. “Swissmedic can get an initial idea of the benefits and risks of vaccine candidates before the study is completed. This speeds up the review process and at the […]

  • There will not be enough vaccines for all EU citizens in 2021
    News

    There will not be enough vaccines for all EU citizens in 2021

    Next year, only a small proportion of people in the European Union will be able to get the coronavirus vaccine. Officials in European countries have not yet decided on the vaccination of citizens. This was announced by Reuters on Tuesday, October 27. “By the end of 2021, there will not be enough doses of the […]

Read also

The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

The “IMC” Agricultural holding will build a dairy farm in the Chernigiv region

The  “Industrial Milk Company” Agricultural holding (IMC, Kiev) plans to build a dairy farm for 700 heads in the Repkinsky district of the Chernigiv region until 2018. This was announced by the  CEO of the company Alex Lissitsa. According to him, the company intends to modernize the dairy complex in the Repkinsky district in the […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
Analytics

Pharmaceutical market of Ukraine: realities and perspectives

In 2013, which experts call the reference, the volume of the pharmaceutical market of Ukraine was about 3.3 billion US dollars. The Pharmaceutical market at that time was one of the fastest growing and took the second place among the CIS countries. According to the consulting company BakerTilly, on average, the market growth rate was […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

SoftBank will sell British Arm Holdings to American Nvidia

In the following days, the Japanese telecommunications holding Softbank intends to sell the large British manufacturer of microprocessors Arm Holdings to one of the world`s leaders in the production of graphics processors, chipsets and software, the American company Nvidia. The deal will be approximately of $ 40 billion. According to the Financial Times, the deal […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Fairfax holding company acquired a part of Astarta shares

International financial company Fairfax Financial Holdings Limited (Toronto headquarters, Canada) purchased 9.99% of shares of agricultural Ukrainian holding Astarta, which is the flagship of the domestic sugar market, which also is one of the largest provider of milk in the country. In addition,a new owner of shares acquired the right to purchase the remaining interest […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
Analytics

Business is a sneaks ruthless policy hostage

The policy of GFS of Ukraine,  directed to the problem resolution of central government budget deficit doesn’t promote business development at all. Entrepreneurs ring the alarm bells! Despite the moratorium of  business checks conducting , the expiring year has remembered by just improbable  actions activation of the Public fiscal service of Ukraine. From practice As […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
Analytics

Healthcare reform in Ukrainian

What are the risks of medical reform in Ukraine? What it must change? Will the industry be funded as stated? Will insurance medicine work and how the market for medical services will be? Medicine established on authorities VS medicine established on evidence In November 2016, the Cabinet of Ministers of Ukraine approved the Concept of […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Ukraine is the world third producer of buckwheat

According to Ukranian Agrarian Business Club (UABC),  Ukraine possess the third place in buckwheat production in the world. China and Russia take the first and second place.The buckwheat production in Ukraine has been characterised by sharp fluctuations within 140-180 thousand tonnes. It was caused by the price of the cultivation. An internal consumption of buckwheat […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Uber stops developing a car without a driver

On Monday, December 7, Uber and startup Aurora Technologies announced an agreement under which Aurora will take over Uber’s Advanced Technologies Group, which has been developing self-governing cars. Under the terms of the agreement, Uber will receive $ 400 million, 26% of Aurora shares, and the general director of the taxi service, Dara Khosrowshahi, will […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Intel announced a breakthrough in transistor technology that will enhance the performance of the new chips by 20%

At the annual press conference as part of “Architecture Day 2020”, Intel has announced improvements in the production of new graphics processors for laptops, PCs and server processors. Positive news was received in not the best time for the company Intel, since July 23, after the close of Thursday, shares fell by more than 20%, […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Naftogaz has found a second partner to develop the offshore shelf

Naftogaz has signed a memorandum with the Israeli company Naphtha Petroleum on possible geological exploration of hydrocarbons on the Black Sea shelf. This was reported by the press service of Ukrgazvydobuvannya. It is noted that Naphtha Petroleum has proven experience with the necessary deepwater technologies and business relationships with leading operators in the development of […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
Analytics

Unlike Sweden which recycles more than 99% of its waste, Ukraine is suffering from rubbish

Only recently, people around the world began to realize that used things accumulated in landfills are not stored there for free. Those who drink dirty water, breathe dirty air suffer from that. People have to see an unpleasant sight and beware of pollution of the surrounding areas… However, this problem can be turned into money, […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Johnson & Johnson suspends the study of the COVID-19 vaccine due to unexplained disease in the participant

Shares of the Johnson & Johnson may slow because the last stimulus to it was the company’s transition to the final clinical trial of the vaccine against COVID-19 on September 23, after which the shares rose by more than 5%. However, as of Tuesday, before the opening of trading, the price of J&J shares did […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Nezhin fat plant invests $ 50 mln. in the construction of oil-extracting factory

Recently was received an information that Nezhin fat plant will invest in the construction of a new oil-extracting factory. The Company appraises  the need for investment in the construction of this plant in the amount of about $ 50 million (of proprietary funds  and borrowed resources). Nezhin fat plant (Chernihiv region) plans to build the […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Coca-Cola sells the manufacturer of “Yarilo” kvass

The Antimonopoly Committee gave the permission to the Nova Trade LTD Baileys company for the  acquisition of more than 50% stake of the company “Kvass Beverages”, which is the part of the Coca-Cola Company Group. This is said in a statement of the regulator. The “Kvass Beverages”Company from Zaporizhzhya  produces kvass of live fermentation under  “Yarilo” […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Yaroslavsky is ready to attract $ 1 billion in investments for the Kharkiv Aircraft Plant

The owner and president of DCH Oleksandr Yaroslavsky is ready to attract $ 1 billion in investments in the restoration of the Kharkiv Aviation Production Enterprise. This statement is published on the official website of the DCH. “The DCH Group is ready to take responsibility for the resumption of domestic aircraft construction and raise $ […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

The Alphabet will invest $ 380 million to Bebor Technologies startup

The parent company of the Google – Alphabet announced that the company will invest to Bebor Technologies $ 380 million, –  reports The Wall Street Journal. According to the deal, the Alphabet company will receive shares in the Bebor Technologies for $ 148 million. Dine Green, one of the head of Alphabet company expressed positive […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com